Jacobson Pharma Corporation Limited reported earnings results for the full year ended March 31, 2022. For the full year, the company reported sales was HKD 1,595.54 million compared to HKD 1,445.92 million a year ago. Net income was HKD 177.67 million compared to HKD 173.71 million a year ago. Basic earnings per share from continuing operations was HKD 0.0927 compared to HKD 0.0907 a year ago. Basic earnings per share was HKD 0.0927 compared to HKD 0.0907 a year ago.